Effect of Metformin on the Epigenetic Age of Peripheral Blood in Patients With Diabetes Mellitus (DM)
Abstract
Abstract Background: Metformin has been proved to have anti-aging effect. However, studies on how metformin affects global epigenetic regulation and its effect on the epigenetic clock in the diabetes mellitus (DM) patients is limited. This study aims to investigate the impact of metformin on the epigenetic age in subjects with type 2 DM.Methods: We collected the peripheral blood of metformin group and the no metformin group of the 32 DM patients. Epigenetic clock was used to estimate the epigenetic age acceleration of the two groups.Results: The results were presented as the following: 1) the metformin slow down the epigenetic age of the DM patients by an average of 2.77 years. 2) we observed a significant enrichment in the regulation of histone methyl-transferase activity (H3K9 specific) 3) we identified 144 differentially methylated positions (DMPs), the top 20 cytosine–guanine dinucleotides (CpGs) and their associate genes with the most consistent changes in the DNA methylation profile were selected: EPM2AIP1, MUC17, FNDC1, HLA-DOB, TRPC4, ESRRB, ADCY2. The major functions of most top-level differential methylation sites and the cellular signaling pathways they represent are related to aging process.Conclusions: Here we demonstrated that metformin could perform an anti-aging effect by slow down the epigenetic clock.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.